Matthew Burge

Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability–High/Mismatch Repair–Deficient Metastatic Colorectal Cancer: KEYNOTE-164

Dung T. Le, Tae Won Kim, Eric Van Cutsem et al. · Journal of Clinical Oncology · 2019 · 1K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer

Jeanne Tie, Joshua D. Cohen, Kamel Lahouel et al. · New England Journal of Medicine · 2022 · 976 citations · Full text

Medicine, Clinical Sciences, Oncology +17

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

Harpreet Wasan, Navesh Sharma, Volker Heinemann et al. · The Lancet Oncology · 2017 · 398 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study

Jeanne Tie, Joshua D. Cohen, Yuxuan Wang et al. · Gut · 2018 · 392 citations

Medicine, Molecular Medicine, Oncology +17

Structured Exercise after Adjuvant Chemotherapy for Colon Cancer

Kerry S. Courneya, Janette L. Vardy, Christopher J. O’Callaghan et al. · New England Journal of Medicine · 2025 · 256 citations

Medicine, Health Education, Oncology +17